Purpose: Sepsis and its progression are known to have a major influence on the coagulation system. Current coagulation tests are of limited use when assessing coagulation in sepsis patients. This study aims to assess the potential for a new functional biomarker of clot microstructure, fractal dimension, to identify changes in the mechanical properties of clot microstructure across the sepsis spectrum (sepsis, severe sepsis and septic shock).
Introduction
Sepsis and its associated underlying inflammatory response are known to exert complex changes on the haemostatic system [1] . Defects in the coagulation system have been implied to contribute to the development of organ dysfunction and poor outcomes in sepsis [2] ; however, clinical trials aiming to correct these defects have so far failed to provide effective new treatments [3] [4] [5] . New insights into haemostasis may help to explain the lack of progress in the treatment of sepsis. Although currently used clinical markers (aPTT and PT) are useful for monitoring anticoagulation, they do not reflect the global picture of coagulation and are insensitive to clinically significant coagulation defects [6] [7] [8] . Rheometry can be used to scientifically quantify the developing mechanical properties of blood as it clots and has recently been identified as a means for quantifying the quality and arrangement of clot microstructure through its fractal dimension (d f ) [9] . d f is measured using whole blood and has been shown to detect hypercoagulable effects even when conventional tests of coagulation do not [10] . Abnormal clot microstructure has recently been detected in patients with both stroke and cancer using d f [10, 11] . However, d f has not been used previously to quantify clot microstructure across the sepsis spectrum. This study hypothesises that the mechanical properties of clot microstructure are significantly altered by the underlying inflammatory response across the sepsis spectrum and that d f is able to detect and identify the changes from the earlier hypercoagulable phase and the hypocoagulable phase of septic shock in terms of clot quality.
The primary aim of this study was to quantify the changes in mechanical clot quality and strength across the stages of sepsis, by using the new marker of clot microstructure, d f .
Some of the data related to the research in this manuscript was presented and published as an abstract in the International Symposium of Intensive Care and Emergency Medicine 2016 prior to the completion of this study [12] .
Methods

Study design
The present study was a single-centre prospective observational study carried out in the emergency department and intensive care unit of a large teaching hospital. This study had full ethical approval from the South West Wales Research Ethics Committee. Informed two-stage written consent was given by patients with capacity to do so. Assent was obtained from personal or legal representation in cases where capacity to give informed consent was lacking.
Recruitment of subjects with sepsis
Subjects that met sepsis criteria as outlined by the American College of Chest Physicians/Society of Critical Care Medicine in 1991 [13] were recruited to this study within 24 h of hospital admission. Patients (age ≥18 years) were included from October 2011 to March 2014. Patients on warfarin or those who had received any treatment likely to affect coagulation (anticoagulation including thromboprophylaxis, component replacement) were excluded. Patients with any pre-existing disease likely to affect the coagulation profile e.g. chronic renal failure, chronic liver disease, malignancy or thrombotic/clotting disorder were also excluded. Furthermore, patients that were deemed insensitive to include i.e. impending death were also excluded from the study.
Patients were categorised as sepsis, severe sepsis or septic shock at the time of inclusion to the study. Categorisation was blinded and carried out by an intensive care specialist independent of the study using the criteria established in 1991 [13] . Sepsis was defined as two or more of the SIRS criteria, with evidence of infection. Severe sepsis was defined as sepsis with at least one acute organ dysfunction [14] whereas septic shock was defined as sepsis with refractory hypotension including perfusion abnormality (lactate >2 mmol/L) in the absence of cardiogenic shock/bleeding.
A group of healthy volunteers matched for age, gender and from a demographically similar population group was recruited as a healthy control.
Blood sampling
Blood was sampled immediately on inclusion to the study. The first 5 mL of blood was discarded, with the following 6.6 mL drawn and immediately placed into the rheometer to determine d f . 
Laboratory markers
Standard coagulation markers (aPTT, PT and fibrinogen) were determined using a Sysmex CA1500 automated analyser within 2 h of collection. Platelet count was determined using a Sysmex XE 2100 automated haematology analyser within 2 h of collection. Factor VIII activity was determined by an aPTT-based one-stage assay using appropriate factor deficient plasma and Actin FS aPTT reagent (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany). D-dimer concentration was determined using TriniLIA Auto-D-dimer ® turbidimetric assay.
Inflammatory markers were determined to quantify the inflammatory response at each stage of the sepsis spectrum and were selected on the basis of previous studies examining the inflammatory effects of sepsis. Concentration of each of the inflammatory markers was measured in platelet-poor plasma using enzyme-linked immunosorbent assay (ELISA) kits for PCT, TNF-α, IL-6 and sE-selectin. The standard methodology was followed as supplied by manufacturer.
Rheometrical analysis
Gel point analysis was performed using rheometry to detect the gel point of the coagulating blood and quantify the fractal microstructure of the fibrin clot at this point (d f ). The methodology carried out in this study has been described in several publications [9, [15] [16] [17] .
Computational analysis
To assess the relationship between d f and fibrin mass at the gel point (incipient clot mass), computer modelling was carried out. A numerical technique which has previously been used to generate random fractal aggregates was used [18, 19] . The algorithm incorporated in this technique uses the box-counting measure of fractal dimension and allows a visual illustration of the incipient clot microstructure to be produced, based on the d f measurements, and also allows for the corresponding fibrin mass to be calculated.
Mature clot imaging: scanning electron microscopy (SEM)
SEM samples were prepared from 12 µL of whole blood using the methodology described previously [10] . The resultant dehydrated blood samples were coated with gold palladium and then imaged using a Hitachi ultrahigh resolution FE-SEM S-4800. Fibrin fibre width was determined from the randomly selected images using the same methodology as has been described previously [20] .
Statistical analysis
This study aimed to investigate significant differences in d f between subjects with sepsis, severe sepsis and septic shock. However, sample size calculation was based on our pilot data and involved detecting the smaller difference in subjects with sepsis, and severe sepsis of 0.07(±SD 0.06). Hence using this minimum value to determine our sample size (expected difference of 0.07, power = 0.9 and SD ± 0.06) and one-way ANOVA at three levels, a minimum sample of at least 15 subjects in each group was required for this study. The data are reported as mean and standard deviation or median and interquartile range where appropriate. Differences in frequency distribution used Chi-squared analysis of nominal data across groups. Students t test assessed differences between normally distributed groups, and Mann-Whitney U test was used for non-normally distributed groups. One-way ANOVA with Bonferroni post hoc correction was used to analyse for multiple group differences or alternatively a Kruskal-Wallis test for non-normally distributed data. Data normality was assessed using the Shapiro-Wilk test with an α value of 0.05. A binomial logistic regression using mortality as the binary response variable and PT and d f as continuous predictor variables. The goodness of fit was determined by the Hosmer-Lemeshow and Pearson methods, and the odds ratios together with their 95 % confidence intervals for the continuous variables were calculated. All statistical analysis was carried out using SPSS for Windows, version 22.0 (Armonk, NY: IBM Corp.).
Results
Baseline characteristics of patient groups
Baseline characteristics of the included patients are shown in Table 1 . A total of 100 sepsis patients were included in the study. This included 50 patients with sepsis, 20 with severe sepsis and 30 with septic shock. Fortyfour healthy volunteers matched for gender and age were also recruited as a healthy control group. Baseline characteristics reflected the severity of each group, with a significantly increased SOFA score, hospital length of stay, mortality and requirement for component replacement observed from sepsis through septic shock.
Changes in standard markers of coagulation across the sepsis spectrum
Changes in coagulation markers across the different groups are shown in Fig. 1 . Standard kinetic markers of coagulation PT and aPTT were significantly prolonged in septic shock (p < 0.001) when compared to other groups. PT was also significantly prolonged in severe sepsis compared to the healthy group (p < 0.005). An increased fibrinogen concentration was observed in sepsis and severe sepsis (p < 0.001) consistent with the underlying inflammatory response of the disease process. In the septic shock group, although fibrinogen concentration was significantly lower than in sepsis (p < 0.01), it remained significantly higher than in the healthy group (p < 0.05). A significantly reduced platelet count was observed in patients with septic shock compared to all other groups (p < 0.05) (Fig. 1) . Factor VIII activity was significantly lower in septic shock than both sepsis (p < 0.05), and severe sepsis (p = 0.001). Furthermore, D dimer was also significantly increased in septic shock compared to sepsis (p < 0.001), indicating increased fibrinolytic activity.
Changes in inflammatory markers across the sepsis spectrum
Inflammatory markers were measured in a subgroup of the total patients to quantify an increasing or decreasing inflammatory response with severity of group (40 sepsis, 13 severe sepsis, 12 septic shock). Baseline measurements for inflammatory markers are shown in Table 2 . A progressive increase in the inflammatory response from sepsis through to septic shock was observed. The inflammatory markers PCT and IL-8 were both significantly elevated in the septic shock group.
Changes in clot microstructure (d f ) across the sepsis spectrum
Changes in d f in the sepsis groups compared to healthy volunteers are shown in Fig. 1 . A d f of 1.74 ± 0.03 was observed in healthy volunteers, which is consistent with the healthy range that has been determined in previous studies [9] [10] [11] . d f was significantly higher in subjects with sepsis and severe sepsis (1.78 ± 0.07 and 1.80 ± 0.05, respectively (p < 0.05)) and significantly lower d f was observed in subjects with septic shock (1.66 ± 0.10 (p < 0.001)). This suggests that clots formed in subjects with sepsis and severe sepsis are structurally dense, with increased fibrin branching and elasticity, whereas in septic shock clots formed are structurally weaker, with a tenuous fibrin structure with reduced branching and elasticity.
Computer modelling of mass change at the incipient clot in relation to d f
It is possible to quantify both the mechanical arrangement of the incipient clot and its mass through computer modelling techniques. Using these techniques previous studies have shown that a relatively small change in d f equates to large changes in the fibrin mass incorporated into the clot [10, 19] . Therefore, to understand and define the change in fibrin mass and connectivity of the incipient clot, computer modelling was carried out (Fig. 2 ). Using this model for incipient clot formation indicates that the patients with the highest d f form an incipient clot with 350 % of the fibrin mass of the control group, whereas the patients with the lowest d f form an incipient clot with 4 % of the normal fibrin mass.
Final clot imaging: scanning electron microscopy
SEM was used to image the mature clot as a qualitative comparison for subjects across the sepsis spectrum. Clots formed from subjects with sepsis were denser and had thinner fibres than healthy individuals. Clots formed from subjects with septic shock appeared looser, with less thinner fibrin fibres than subjects with sepsis (Fig. 3) .
Comparison between survivors and non-survivors at 28 days
All patients were followed up for all-cause 28-day mortality. Characteristics of survivors and non-survivors at 28 days are shown in Supplementary Table 1. A significant trend towards hypocoagulability was apparent in non-survivors compared to survivors. Poor outcome was associated with a prolonged PT and reduced fibrinogen concentration. A weaker clot microstructure was also significantly associated with poor outcome, as indicated by significantly lower values of d f in patients that did not survive 28 days. Furthermore, IL-8 and PCT were significantly associated with poor outcomes.
Binary logistic regression was undertaken on the two most significant coagulation variables (PT and d f ) as a predictor of mortality. PT and d f were found to be significant predictors of mortality (p < 0.0005) with odds ratios of 1.54 (CI 1.12-2.12) and 0.10 (CI 0.00-0.21), respectively. The odds ratio of less than 1 for d f confirmed the significant effect of a lowered d f on survival.
Discussion
This study demonstrates for the first time that a new functional biomarker of clot microstructure, d f , can act as a significant biomarker for characterising changes in the mechanical properties of the clot in both the hyper-and hypocoagulable phases of sepsis.
Previous studies have shown how d f is an accurate determinant for defining both the developing and the final clot architecture in acute vascular inflammatory conditions [11] . Increases in d f have previously been shown to be characteristically associated with hypercoagulable states of vascular inflammatory disease and increasing clot strength [10, 11] , whereas reduced values of d f are associated with hypocoagulable states and a weakening of the mechanical clot properties [11, 20] , [21] .
In the present study, we describe for the first time the changes that occur in clot microstructure across the clinically recognised stages of the sepsis spectrum. A significant increase in d f was observed in patients with sepsis and severe sepsis, corresponding to formation of a tight, highly elastic incipient clot that is potentially more resistant to fibrinolysis. In septic shock, there was a significantly lower d f , corresponding to formation of a loose, structurally weak incipient clot that is potentially more susceptible to fibrinolysis.
As in previous studies the present study indicated a significant increase in the inflammatory response in septic shock [22] . Despite this increased inflammatory response, there was a profound reduction in d f and mechanical strength of the developing clot in septic shock. There are multiple factors that could contribute to this hypocoagulable effect. It has been shown that activity of clotting factors is reduced in septic shock, and this culminates in delayed and reduced thrombin generation [23] . This impairment of thrombin generation could lead to a lack of available fibrin to be incorporated into the incipient clot. Furthermore, in the present study patients with septic shock were significantly more acidotic and hypothermic, both of which have been shown to induce hypocoagulable effects and affect fibrin polymerisation and clot strength [15, 24] .
In the hypercoagulable phases of sepsis and severe sepsis there was a significant increase in fibrinogen concentration, which is a known finding associated with the acute inflammatory response in sepsis [25] . In septic shock, fibrinogen concentration still remained significantly elevated when compared with the healthy control, whereas there was a corresponding significant and marked reduction in d f . This indicates that although there is an adequate concentration of fibrinogen in septic shock, the organisation of the fibrin clot microstructure formed was mechanically weak and porous compared to the matched healthy control group. This was confirmed in the SEM, where it was noted that there was an open clot, with visibly reduced incorporation of fibrin and branching which was also reflected by fibre width.
The present study utilising d f scientifically determines and quantifies how mechanical clot strength in terms of its cross linking and connectivity changes as sepsis progresses. Donze et al. showed that with increasing severity of sepsis there is an increase in prothrombotic tendency and occurrence of thromboembolic events [26] . In this study d f indicated a significant procoagulant change in clot microstructure in sepsis and severe sepsis, which could contribute to the recognised increased incidence of thromboembolic events [26] . Previous studies have shown how patients in septic shock undergo haemostatic changes due to consumption and coagulopathic effects, which could result in bleeding tendency [27, 28] . It is difficult to assess the relative risk of bleeding in septic shock, however, with previous studies reporting the incidence of major bleeding events at between 1 and 20 % [3, 29, 30] , but no definitive study quantifying this bleeding risk. In this study, it was highlighted that despite sufficient platelet numbers and fibrinogen concentration in septic shock, there was still the inability to form a mechanically stable clot, as highlighted by d f .
Comparison of d f against standard clinical markers of coagulation showed that in the hypercoagulable phase of sepsis, the standard markers were normal, despite an increased d f . This confirms the lack of sensitivity of the standard markers of coagulation to hypercoagulable changes in sepsis. In septic shock there was as significant prolongation of aPTT and PT, which corresponded to a significant reduction in d f . It is well recognised that both thrombin generation and fibrinolytic function can be impaired in septic shock [27, 31] . Overall, these complex haemostatic changes can lead to a dichotomy, where a patient may have thromboembolic risk, but still be at risk of a bleeding diathesis, both of which may be clinically difficult to evaluate in the intensive care setting. Although in this study we did not look at clinical outcomes or underlying mechanisms, d f clearly quantified how the changes and the balance between the pro-and anticoagulant effects of coagulation could be assessed in terms of clot characteristics and strength.
To investigate the structural characteristics of the mature clot across the sepsis spectrum and its relationship to d f , we used SEM imaging. It has been shown previously that in hypercoagulable states, there is increased fibrin binding with an associated increase in fibrin mass and density of branching [32] . In this study it was confirmed that there was an alteration in clot microstructure in the different stages of sepsis, which has not been shown before. In the early hypercoagulable stages, SEM images showed increased branching, reduced poor space and thinner fibrin fibres. Conversely in septic shock, it was noted that although thinner fibrin fibres were observed, similar to in hypercoagulable states, the cross linking was reduced and pore spaces appeared larger, indicating a loosening of the clot architecture and implying a looser, weaker final clot structure due to less fibrinogen being incorporated into the polymerised clot mass.
Altered clot structure and its mechanical properties were further investigated using computer modelling, where it was indicated that higher values of d f were associated with a much greater polymerised fibrin mass of high connectivity consistent with a prothrombotic or hypercoagulable state. For the highest values of d f that were observed, computer modelling indicated a corresponding 350 % increase in fibrin mass incorporated into the clot, whereas for the lowest values of d f the incipient clot had a fibrin mass of less than 10 % of that incorporated into a healthy clot.
In previous studies it was shown that d f can characterise the mechanisms of clot microstructure in inflammatory diseased states at their various stages [10] . This study again confirms and gives further evidence that characterisation of clot architecture across the sepsis spectrum may further our understanding of the effects of sepsis and its inflammatory response on the coagulation system. However, further mechanistic studies are required to explore and determine the factors that underpin these changes in clot microstructure in patients who move from severe sepsis to septic shock. Further studies are underway to explore these mechanistic possibilities and also to investigate how these changes affect clinical outcome.
Limitations
This study has a number of limitations. Firstly this was a single-centre observational study, and although some outcome data were presented, they were not powered for clinical outcome, as this was a proof of concept study. Furthermore, it was outside the scope of this study to seek mechanistic conclusions. The inherent problem of this study and other similar studies is the heterogeneity of the disease, its treatment and comorbidities. It is also difficult to take into account the possible differences in concomitant medications and treatment between the groups. To assess these effects fully a much larger study would be required. Further larger prospective studies are required to build on the findings of this study.
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